SIP
DRTX

Stoneridge Investment Partners’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Stoneridge Investment Partners’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-30,732
Closed -$278K – 249
2013
Q3 		$278K Buy
+30,732
New +$255K 0.06% 158

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stoneridge Investment Partners's DRTX Position: Q4 2013 in Review

Stoneridge Investment Partners sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2013, closing a stake of 30,732 shares — an estimated $278K sold.

Stoneridge Investment Partners first reported a position in DRTX in Q3 2013 and held it in 1 quarter. The position peaked at $278K in Q3 2013. 46 funds tracked by Wall St. Rank hold DRTX as of Q4 2013.

  • Stoneridge Investment Partners reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Stoneridge Investment Partners sold 30,732 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2013, an estimated $278K.
  • Stoneridge Investment Partners first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 1 quarter.
  • Stoneridge Investment Partners's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $278K in Q3 2013.
  • 46 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2013.

Based on Stoneridge Investment Partners's 13F filing for Q4 2013, filed 14 Jan 2014.